Vivimed Labs Ltd.

₹7.31

+ 0.31 (4.43%)

04:01 pm - close price

BSE: VIVIMEDLAB

NSE: VIVIMEDLAB

Industry: Pharmaceuticals & Drugs

House: Private

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: -3.85Good: 5

❌

Adjusted EPS

Bad: 3Current: -3.85Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -9.07Good: 20

❌

Current Ratio

Bad: 1Current: 0.80Good: 2

❌

Return On Equity (ROE)

N/A

❌

Debt to Total Assets

Bad: 1Current: 40.87Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: -3.85Good: 5

❌

Adjusted EPS

Bad: 3Current: -3.85Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -9.07Good: 20

❌

Current Ratio

Bad: 1Current: 0.80Good: 2

❌

Return On Equity (ROE)

N/A

❌

Debt to Total Assets

Bad: 1Current: 40.87Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-03	2023-06	2023-09	2023-12
Net Sales	37.03	35.35	33.64	41.46
Expenditure+	201.32	35.68	39.54	40.19
Other Income+	0.68	0.11	2.20	0.04
Operating Profit	-164.29	-0.33	-5.90	1.27
Interest	8.52	10.66	11.89	13.21
Depreciation and Amortization	95.92	4.70	4.70	4.70
Profit Before Tax	-268.05	-15.57	-20.30	-16.60
Tax+	-2.06	0.00	0.00	-0.55
Net Profit	-265.99	-15.57	-20.30	-16.05

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	8614.67	2372.87	1870.99	1490.71	1162.69
Operational Expenses+	8295.88	2451.14	3740.86	1819.45	1292.83
Operating Profit	318.79	-78.27	-1869.87	-328.74	-130.14
Other Income	98.23	12.70	9.68	99.76	43.71
OPM %	3.70	-3.30	-99.94	-22.05	-11.19
Depreciation and Amortisation	554.95	182.83	1084.07	199.41	202.25
Interest	560.64	399.93	362.27	29.84	29.80
Profit Before Tax	-698.57	-648.33	-3306.53	-458.23	-318.48
Tax	20.29	28.17	-21.17	-3.95	1.13
Net Profit	-718.86	-676.50	-3285.36	-454.46	-319.61

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	12893.29	12660.13	9952.05	9508.62	9208.46
Liabilities+	12893.29	12660.13	9952.05	9508.62	9208.46

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	5672.75	275.40	353.22	-239.91	-17.51
Cash from Investing Activity	4040.01	-164.10	-49.68	282.87	-45.31
Cash from Financing Activity	-10153.32	-103.78	-337.76	-60.33	49.64
Net Cash Flow	-440.56	7.52	-34.22	-17.37	-13.18
Opening Cash & Cash Equivalents	504.87	64.32	71.84	37.62	20.26
Closing Cash & Cash Equivalents	64.31	71.84	37.62	20.25	7.08

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	7.77	7.77	7.77	20.94	20.94	20.94	20.94	20.94	20.94	20.94
Public+	92.23	92.23	92.23	79.06	79.06	79.06	79.06	79.06	79.06	79.06
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	49221	48925	48928	48957	49005	49003	49012	49016	49027	49038

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: -3.85Good: 5

❌

Adjusted EPS

Bad: 3Current: -3.85Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -9.07Good: 20

❌

Current Ratio

Bad: 1Current: 0.80Good: 2

❌

Return On Equity (ROE)

N/A

❌

Debt to Total Assets

Bad: 1Current: 40.87Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: -3.85Good: 5

❌

Adjusted EPS

Bad: 3Current: -3.85Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -9.07Good: 20

❌

Current Ratio

Bad: 1Current: 0.80Good: 2

❌

Return On Equity (ROE)

N/A

❌

Debt to Total Assets

Bad: 1Current: 40.87Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Quarterly Results

In Rs. Cr.	2023-03	2023-06	2023-09	2023-12
Net Sales	37.03	35.35	33.64	41.46
Expenditure+	201.32	35.68	39.54	40.19
Other Income+	0.68	0.11	2.20	0.04
Operating Profit	-164.29	-0.33	-5.90	1.27
Interest	8.52	10.66	11.89	13.21
Depreciation and Amortization	95.92	4.70	4.70	4.70
Profit Before Tax	-268.05	-15.57	-20.30	-16.60
Tax+	-2.06	0.00	0.00	-0.55
Net Profit	-265.99	-15.57	-20.30	-16.05

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	8614.67	2372.87	1870.99	1490.71	1162.69
Operational Expenses+	8295.88	2451.14	3740.86	1819.45	1292.83
Operating Profit	318.79	-78.27	-1869.87	-328.74	-130.14
Other Income	98.23	12.70	9.68	99.76	43.71
OPM %	3.70	-3.30	-99.94	-22.05	-11.19
Depreciation and Amortisation	554.95	182.83	1084.07	199.41	202.25
Interest	560.64	399.93	362.27	29.84	29.80
Profit Before Tax	-698.57	-648.33	-3306.53	-458.23	-318.48
Tax	20.29	28.17	-21.17	-3.95	1.13
Net Profit	-718.86	-676.50	-3285.36	-454.46	-319.61

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	12893.29	12660.13	9952.05	9508.62	9208.46
Liabilities+	12893.29	12660.13	9952.05	9508.62	9208.46

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	5672.75	275.40	353.22	-239.91	-17.51
Cash from Investing Activity	4040.01	-164.10	-49.68	282.87	-45.31
Cash from Financing Activity	-10153.32	-103.78	-337.76	-60.33	49.64
Net Cash Flow	-440.56	7.52	-34.22	-17.37	-13.18
Opening Cash & Cash Equivalents	504.87	64.32	71.84	37.62	20.26
Closing Cash & Cash Equivalents	64.31	71.84	37.62	20.25	7.08

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	7.77	7.77	7.77	20.94	20.94	20.94	20.94	20.94	20.94	20.94
Public+	92.23	92.23	92.23	79.06	79.06	79.06	79.06	79.06	79.06	79.06
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	49221	48925	48928	48957	49005	49003	49012	49016	49027	49038

Vivimed Labs Ltd.

₹7.31

+ 0.31 (4.43%)

04:01 pm - close price

BSE: VIVIMEDLAB

NSE: VIVIMEDLAB

Industry: Pharmaceuticals & Drugs

House: Private

Overview